Killing puts spotlight on easy availability of habit-forming drugs; Punjab steps up chemist checks

The tragic death of an individual in Punjab has sparked a public debate about the accessibility of prescription medicines that have a high potential for abuse. Authorities have identified pregabalin, a medication commonly prescribed for nerve pain and anxiety, as a substance that is being obtained without proper medical oversight. In response, the Punjab government has announced a series of measures aimed at tightening control over the distribution of the drug, including more frequent and thorough inspections of chemist shops across the state.

Starting on November 12, new regulations will require pharmacists to verify prescriptions more rigorously before dispensing pregabalin. The rules also mandate that pharmacies maintain detailed records of each sale, which will be subject to random audits by health officials. These steps are intended to curb the illicit market for the drug, which has been linked to a rise in dependence and related health problems. The government has emphasized that the restrictions are part of a broader effort to address substance abuse while still ensuring that patients with legitimate medical needs can access treatment.

Public health experts note that controlling the supply of habit‑forming medicines can reduce the incidence of addiction and associated social costs. Community groups have welcomed the crackdown, urging further education campaigns to raise awareness about the risks of self‑medication. As the new rules come into force, officials will monitor compliance and may adjust the policy based on observed outcomes. The initiative reflects a growing recognition that proactive regulation is essential to protect public health in Punjab.